Chemotherapy of leishmaniasis: recent advances in the treatment of visceral disease

被引：21

作者：

Berman, J ^{[1
]}

机构：

[1] Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Washington, DC 20307 USA

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 1998年 / 11卷 / 06期

关键词：

D O I：

10.1097/00001432-199812000-00009

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

New lipid formulations of amphotericin B - AmBisome, Amphotec, and Abelcet - have dramatically decreased the toxicity associated with amphotericin B and have made this group of agents the treatment of choice for visceral leishmaniasis, An agent of a completely different chemical class, the aminoglycoside aminosidine, was 97% curative in India. This agent too may be used for visceral leishmaniasis, Curr Opin Infect Dis 11:707-710. (C) 1998 Lippincott Williams & Wilkins.

引用

页码：707 / 710

页数：4

共 13 条

[1] Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].

Alvar, J ;

Canavate, C ;

GutierrezSolar, B ;

Jimenez, M ;

Laguna, F ;

LopezVelez, R ;

Molina, R ;

Moreno, J .

CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+

[2]

Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25

[3] Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].

Berman, JD .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703

[4] TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA BY AMINOSIDINE ALONE OR COMBINED WITH SODIUM STIBOGLUCONATE [J].

CHUNGE, CN ;

OWATE, J ;

PAMBA, HO ;

DONNO, L .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1990, 84 (02) :221-225

[5] Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome) [J].

Davidson, RN ;

diMartino, L ;

Gradoni, L ;

Giacchino, R ;

Gaeta, GB ;

Pempinello, R ;

Scotti, S ;

Cascio, A ;

Castagnola, E ;

Maisto, A ;

Gramiccia, M ;

diCaprio, D ;

Wilkinson, RJ ;

Bryceson, ADM .

CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :938-943

[6]

DAVIDSON RN, 1994, Q J MED, V87, P75

[7] Leishmaniasis - Public health aspects and control [J].

Desjeux, P .

CLINICS IN DERMATOLOGY, 1996, 14 (05) :417-423

[8] TREATMENT OF KALA-AZAR IN BRAZIL WITH AMPHOCIL(R) (AMPHOTERICIN-B CHOLESTEROL DISPERSION) FOR 5 DAYS [J].

DIETZE, R ;

FAGUNDES, SMS ;

BRITO, EF ;

MILAN, EP ;

FEITOSA, TF ;

SUASSUNA, FAB ;

FONSCHIFFREY, G ;

KSIONSKI, G ;

DEMBER, J .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (03) :309-311

[9] TREATMENT OF BRAZILIAN KALA-AZAR WITH A SHORT-COURSE OF AMPHOCIL (AMPHOTERICIN-B CHOLESTEROL DISPERSION) [J].

DIETZE, R ;

MILAN, EP ;

BERMAN, JD ;

GROGL, M ;

FALQUETO, A ;

FEITOSA, TF ;

LUZ, KG ;

SUASSUNA, FAB ;

MARINHO, LAC ;

KSIONSKI, G .

CLINICAL INFECTIOUS DISEASES, 1993, 17 (06) :981-986

[10] Randomised controlled trial of aminosidine (paromomycin) υ sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India [J].

Jha, TK ;

Olliaro, P ;

Thakur, CPN ;

Kanyok, TP ;

Singhania, BL ;

Singh, IJ ;

Singh, NKP ;

Akhoury, S ;

Jha, S .

BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1200-1205

← 1 2 →